Literature DB >> 12742821

Expression levels strongly affect ligand-induced sequestration of B2 bradykinin receptors in transfected cells.

Alexander Faussner1, Alexandra Bauer, Irina Kalatskaya, Marianne Jochum, Hans Fritz.   

Abstract

Transfection of cells with expression vectors is one of the most important tools used to assess the effects of receptor mutations on ligand-induced receptor sequestration. Most transfection methods give rise to transiently or stably transfected clones with a wide range of receptor expression levels that may also depend on the mutations made. It is, therefore, important to determine how the regulation of the receptors depends on their numbers per cell. In Chinese hamster ovary (CHO) and human embryonic kidney (HEK)-293 cells expressing high levels of B(2) kinin receptors, we observed poor sequestration indicated by <20% reduction in cell surface receptor number after 10 min of stimulation with 1 microM bradykinin (BK) compared with >70% in low-expressing cells. Whereas the rate of [(3)H]BK internalization (internalized [(3)H]BK in percentage of total bound [(3)H]BK) in low-expressing cells was independent of the ligand-concentration used, in high-expressing cells a strong rate decrease was observed with higher (>1 nM) concentrations. Lower ligand concentrations, however, led to internalization rates identical to those obtained in low-expressing cells. Transiently transfected HEK and COS-7 cells showed results similar to those of stably high-expressing cells. Our results demonstrate the difficulty in determining the internalization pattern of (mutated) B(2) kinin receptors, and possibly of G protein-coupled receptors in general, using a sequestration assay in high-expressing cells or transiently transfected cells with high numbers of receptors per transfected cell. However, the receptor (mutant)-specific internalization rate can be measured, provided that the ligand concentrations used are below a threshold at which the internalization rate is still independent of the ligand concentration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12742821     DOI: 10.1152/ajpheart.01147.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  6 in total

1.  Helix 8 plays a crucial role in bradykinin B(2) receptor trafficking and signaling.

Authors:  Jens Feierler; Markus Wirth; Benjamin Welte; Steffen Schüssler; Marianne Jochum; Alexander Faussner
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

2.  Binding characteristics of [3H]-JSM10292: a new cell membrane-permeant non-peptide bradykinin B2 receptor antagonist.

Authors:  A Faussner; S Schüssler; J Feierler; M Bermudez; J Pfeifer; K Schnatbaum; T Tradler; M Jochum; G Wolber; C Gibson
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

3.  Regulation of human organic anion transporter 3 by peptide hormone bradykinin.

Authors:  Shanshan Li; Peng Duan; Guofeng You
Journal:  J Pharmacol Exp Ther       Date:  2010-03-18       Impact factor: 4.030

4.  Identification of functional bradykinin B(2) receptors endogenously expressed in HEK293 cells.

Authors:  Inga I Kramarenko; Marlene A Bunni; Thomas A Morinelli; John R Raymond; Maria N Garnovskaya
Journal:  Biochem Pharmacol       Date:  2008-10-01       Impact factor: 5.858

5.  Kinin-stimulated B1 receptor signaling depends on receptor endocytosis whereas B2 receptor signaling does not.

Authors:  Johan Enquist; Caroline Sandén; Carl Skröder; Sandra A Mathis; L M Fredrik Leeb-Lundberg
Journal:  Neurochem Res       Date:  2013-08-10       Impact factor: 3.996

6.  Optimization of the Heterologous Expression of the Cannabinoid Type-1 (CB1) Receptor.

Authors:  Viktória B Horváth; Eszter Soltész-Katona; Éva Wisniewski; Anikó Rajki; Eszter Halász; Balázs Enyedi; László Hunyady; András Dávid Tóth; Gergő Szanda
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-20       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.